Top Cities for Recurrent Pregnancy Loss Clinical Trials
Recurrent Pregnancy Loss clinical trials are recruiting across 9 cities. Here are the cities with the most active studies:
About Recurrent Pregnancy Loss
Recurrent pregnancy loss is defined as two or more failed pregnancies and affects about 1-2% of couples trying to conceive. Causes include chromosomal abnormalities, uterine anomalies, and immune factors. Treatment depends on the underlying cause and may include hormonal support, surgery, or immunotherapy.
Clinical trials are advancing new treatments for recurrent pregnancy loss. Currently, 1 studies are recruiting a combined 150 participants across the United States. Research is being conducted by 1 organizations including Crinetics Pharmaceuticals Inc..
2026 Recurrent Pregnancy Loss Research Landscape
As of March 2026, the recurrent pregnancy loss clinical trial landscape includes 1 actively recruiting studies across 9 cities in the United States. These studies are collectively seeking 150 participants, with an average enrollment target of 150 per study.
Research is being led by 1 organization, including Crinetics Pharmaceuticals Inc..
Geographically, recurrent pregnancy loss trials are most concentrated in Minneapolis, Minnesota (1 trial); Morehead City, North Carolina (1 trial); Córdoba, Córdoba Province (1 trial); Botucatu, São Paulo (1 trial); São Paulo, (1 trial) and 4 other cities.
Featured Recurrent Pregnancy Loss Studies
Highlighted recruiting studies for recurrent pregnancy loss, selected by enrollment size and research scope.
An Extension Study to Evaluate Safety and Efficacy in Participants Treated With CRN04894
The purpose of this study is to evaluate the long-term safety, tolerability, and efficacy of atumelnant (CRN04894).
Frequently Asked Questions About Recurrent Pregnancy Loss Clinical Trials
Are there recurrent pregnancy loss clinical trials near me?
Yes, there are 1 recurrent pregnancy loss clinical trials currently recruiting across 9+ cities in the United States, including Minneapolis, Minnesota; Morehead City, North Carolina; Córdoba, Córdoba Province. Browse the studies above to find one at a location convenient for you.
How do I join a recurrent pregnancy loss clinical trial?
To join a recurrent pregnancy loss clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are recurrent pregnancy loss clinical trials free?
Yes, participation in recurrent pregnancy loss clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of recurrent pregnancy loss treatments are being studied?
Current recurrent pregnancy loss clinical trials are testing a range of approaches. These include new drugs, combination therapies, medical devices, and other interventions sponsored by 1 research organizations.
Is it safe to participate in recurrent pregnancy loss clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated March 1, 2026 from ClinicalTrials.gov
About This Data
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated March 1, 2026 · Data from ClinicalTrials.gov